After 25 years with the NIH, Dr. Jack M. Guralnik, Chief of the Laboratory of Epidemiology, Demography and Biometry (LEDB) retired from his position on January 1, 2011.
With Dr. Guralnik’s departure, Lenore J. Launer, Ph.D., has taken on the role of Acting Chief of LEDB.
After 21 years of service Dr. Anna McCormick retired from NIA service on December 31, 2010. Dr. McCormick was Chief of the Genetics and Cell Biology Branch in DAB.
After a search, DAB has hired Dr. Max Guo to serve as the new Branch Chief. Dr. Guo obtained his B.S. at Peking University in China, and a Ph. D. in Biochemistry at Ohio State University with Dr. Alan Lambowitz. He then did postdoctoral training in the laboratory of Nobel Prize winner Dr. Michael Bishop before joining the NIH in 1997. Dr. Guo is currently the Deputy Director of the Division of Metabolism and Health Effects at the National Institute on Alcohol Abuse and Alcoholism (NIAAA). He will start at NIA on May 22, 2011.
Barbara Radziszewska, Ph.D., MPH has joined DGCG’s Clinical Trials Branch. Dr. Radziszewska has extensive and productive experience in developing and managing NIH clinical trials. Prior to joining NIA she worked with DGCG on our Testosterone trial. She has a strong interest in aging topics, and will be administering our multicenter trial of aspirin in the elderly, among others.